Should treatment of low-level rifampicin mono-resistant tuberculosis be different?
作者信息
Van Deun Armand, Decroo Tom
机构信息
Independent Consultant, 3000 Leuven, Belgium.
Institute of Tropical Medicine, Unit of HIV and TB, Department of Clinical Sciences, 2000 Antwerp, Belgium.
出版信息
J Clin Tuberc Other Mycobact Dis. 2021 Apr 28;23:100240. doi: 10.1016/j.jctube.2021.100240. eCollection 2021 May.
Abstract
摘要
相似文献
1
Should treatment of low-level rifampicin mono-resistant tuberculosis be different?
J Clin Tuberc Other Mycobact Dis. 2021 Apr 28;23:100240. doi: 10.1016/j.jctube.2021.100240. eCollection 2021 May.
2
Rifampicin resistance mutations in the 81 bp RRDR of rpoB gene in Mycobacterium tuberculosis clinical isolates using Xpert MTB/RIF in Khyber Pakhtunkhwa, Pakistan: a retrospective study.
BMC Infect Dis. 2016 Aug 12;16:413. doi: 10.1186/s12879-016-1745-2.
3
Diagnosis of rifampicin-resistant tuberculosis: Discordant results by diagnostic methods.
Afr J Lab Med. 2018 Dec 6;7(2):806. doi: 10.4102/ajlm.v7i2.806. eCollection 2018.
4
Effect of Xpert MTB/RIF on the treatment of multi-drug-resistant or rifampicin-resistant tuberculosis screened out from re-treatment pulmonary tuberculosis patients, a prospective cohort study.
Ann Palliat Med. 2020 Mar;9(2):239-246. doi: 10.21037/apm.2020.02.17. Epub 2020 Mar 17.
5
Successful Treatment of a Multidrug-Resistant Tuberculosis Patient with a Negative Xpert MTB/RIF Test for Rifampicin-Resistant Tuberculosis in Guizhou Province of China: A Case Report.
Infect Drug Resist. 2020 May 8;13:1351-1355. doi: 10.2147/IDR.S245219. eCollection 2020.
6
Epidemiology of Rifampicin Resistant Tuberculosis and Common Mutations in rpoB Gene of Mycobacterium tuberculosis: A Retrospective Study from Six Districts of Punjab (India) Using Xpert MTB/RIF Assay.
J Lab Physicians. 2016 Jul-Dec;8(2):96-100. doi: 10.4103/0974-2727.180789.
7
Xpert MTB/RIF for rapid detection of rifampicin-resistant Mycobacterium tuberculosis from pulmonary tuberculosis patients in Southwest Ethiopia.
Int J Mycobacteriol. 2016 Dec;5 Suppl 1:S48-S49. doi: 10.1016/j.ijmyco.2016.09.002. Epub 2016 Nov 5.
8
Diagnostic Efficacy, Sensitivity, and Specificity of Xpert MTB/RIF Assay for Spinal Tuberculosis and Rifampicin Resistance.
Spine (Phila Pa 1976). 2020 Feb 1;45(3):163-169. doi: 10.1097/BRS.0000000000003225.
9
EBUS-TBNA in the rapid microbiological diagnosis of drug-resistant mediastinal tuberculous lymphadenopathy.
ERJ Open Res. 2019 Nov 15;5(4). doi: 10.1183/23120541.00008-2019. eCollection 2019 Oct.
10
Xpert MTB/RIF performance to diagnose tuberculosis and rifampicin resistance in a reference centre in southern Brazil.
ERJ Open Res. 2019 Aug 5;5(3). doi: 10.1183/23120541.00043-2019. eCollection 2019 Jul.
本文引用的文献
1
Should treatment of low-level rifampicin mono-resistant tuberculosis be different?
J Clin Tuberc Other Mycobact Dis. 2021 Jan 29;23:100222. doi: 10.1016/j.jctube.2021.100222. eCollection 2021 May.
2
Outbreak of multidrug-resistant tuberculosis in South Africa undetected by WHO-endorsed commercial tests: an observational study.
Lancet Infect Dis. 2018 Dec;18(12):1350-1359. doi: 10.1016/S1473-3099(18)30496-1. Epub 2018 Oct 18.
3
Rifampin resistance missed in automated liquid culture system for Mycobacterium tuberculosis isolates with specific rpoB mutations.
J Clin Microbiol. 2013 Aug;51(8):2641-5. doi: 10.1128/JCM.02741-12. Epub 2013 Jun 12.
4
Rifampin drug resistance tests for tuberculosis: challenging the gold standard.
J Clin Microbiol. 2013 Aug;51(8):2633-40. doi: 10.1128/JCM.00553-13. Epub 2013 Jun 12.
5
Evaluation of the analytical performance of the Xpert MTB/RIF assay.
J Clin Microbiol. 2010 Jul;48(7):2495-501. doi: 10.1128/JCM.00128-10. Epub 2010 May 26.
6
Genome analysis of multi- and extensively-drug-resistant tuberculosis from KwaZulu-Natal, South Africa.
PLoS One. 2009 Nov 5;4(11):e7778. doi: 10.1371/journal.pone.0007778.
7
Studies on the treatment of tuberculosis undertaken by the British Medical Research Council tuberculosis units, 1946-1986, with relevant subsequent publications.
Int J Tuberc Lung Dis. 1999 Oct;3(10 Suppl 2):S231-79.
8
Primary resistance to antituberculosis drugs: a national survey conducted in Côte d'Ivoire in 1995-1996. Ivoirian Study Group on Tuberculosis Resistance.
Int J Tuberc Lung Dis. 1999 Sep;3(9):805-9.
Zotero 插件